275 related articles for article (PubMed ID: 28651408)
1. [Identification and evaluation of T cell epitopes of Rv0585c from
Wang XX; Chen X; Li YQ; Xiao TY; Jiang Y; Li MC; Liu HC; Wan KL
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):665-669. PubMed ID: 28651408
[No Abstract] [Full Text] [Related]
2. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
[TBL] [Abstract][Full Text] [Related]
3. Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis.
Wang X; Chen S; Xu Y; Zheng H; Xiao T; Li Y; Chen X; Huang M; Zhang H; Fang X; Jiang Y; Li M; Liu H; Wan K
Emerg Microbes Infect; 2017 Jun; 6(6):e48. PubMed ID: 28588287
[TBL] [Abstract][Full Text] [Related]
4. [Immune effects research of interleukin 12 and Mycobacterium tuberculosis ESAT-6 antigen combined DNA immunization].
Hao M; Bao L; Gao L
Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):477-81. PubMed ID: 17672309
[TBL] [Abstract][Full Text] [Related]
5. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
Kim A; Hur YG; Gu S; Cho SN
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
[TBL] [Abstract][Full Text] [Related]
6. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine with discontinuous T-cell epitope insertions into HSP65 scaffold as a potential means to improve immunogenicity of multi-epitope Mycobacterium tuberculosis vaccine.
Wu M; Li M; Yue Y; Xu W
Microbiol Immunol; 2016 Sep; 60(9):634-45. PubMed ID: 27531823
[TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv.
Fatma F; Tripathi DK; Srivastava M; Srivastava KK; Arora A
Tuberculosis (Edinb); 2021 Mar; 127():102054. PubMed ID: 33550109
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel immunodominant antigen Rv2645 from RD13 with potential as a cell-mediated immunity-based TB diagnostic agent.
Luo W; Qu ZL; Xie Y; Xiang J; Zhang XL
J Infect; 2015 Nov; 71(5):534-43. PubMed ID: 26318635
[TBL] [Abstract][Full Text] [Related]
10. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis.
Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J
Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013
[TBL] [Abstract][Full Text] [Related]
12. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
[TBL] [Abstract][Full Text] [Related]
13. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c].
Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X
Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525
[TBL] [Abstract][Full Text] [Related]
14. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
[TBL] [Abstract][Full Text] [Related]
15. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes.
McMurry J; Sbai H; Gennaro ML; Carter EJ; Martin W; De Groot AS
Tuberculosis (Edinb); 2005; 85(1-2):95-105. PubMed ID: 15687033
[TBL] [Abstract][Full Text] [Related]
16. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
D'Souza S; Rosseels V; Romano M; Tanghe A; Denis O; Jurion F; Castiglione N; Vanonckelen A; Palfliet K; Huygen K
Infect Immun; 2003 Jan; 71(1):483-93. PubMed ID: 12496199
[TBL] [Abstract][Full Text] [Related]
17. Construction and immunogenicity of the DNA vaccine of Mycobacterium Tuberculosis dormancy antigen rv1733c.
Zhang W; Jiang H; Bai YL; Kang J; Xu ZK; Wang LM
Scand J Immunol; 2014 May; 79(5):292-8. PubMed ID: 24498941
[TBL] [Abstract][Full Text] [Related]
18. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
19. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
[TBL] [Abstract][Full Text] [Related]
20. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]